Cite

HARVARD Citation

    Gray, E. et al. (2016). Direct costs of interferon‐based and interferon‐free direct‐acting antiviral regimens for the treatment of chronic hepatitis C infection. Journal of viral hepatitis. 23 (9), pp. 677-686. [Online]. 
  
Back to record